DAFTAR PUSTAKA 1. Zaenglein AL, Graber EM, Thiboutot DM, et al. Acne vulgaris and acneiform eruptions. Dalam : Wolff K, Goldsmith LA, Katz SI, et al. Fitzpatrick s Dermatology in General Medicine. Volume 1, edisi ke-7. Mc.Graw Hill Company, New York, 2008.h.690-700. 2. Thiboutot D. Acne : hormonal concepts and therapy. Clinics in Dermatology 2004;22:419-28. 3. Cara JF, Rosenfield RL, Furlanetto RW. A longitudinal of the relationship of plasma somatomedin-c concentration to the pubertal growth spurt. Am J Dis Child 1987;141(5):562-4. 4. Burton JL, Libman LJ, Cunliffe WJ, et al. Sebum excretion in acromegaly. British Medical Journal 1982,1,406-8. 5. Ebling FJ, Ebling E, Randall V, et al. The effects of hypophysectomy and of bovine growth hormone on the responses to testosterone of prostate, preputial, harderian and lacrymal glands and of brown adipose tissue in the rat. J Endocrinol 1975;66:401-6. 6. Deplewski D, Rosenfield RL. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 1999;140:4089-94. 7. Smith TM, Gilliland K, Clawson GA, et al. IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway. J Invest Dermatol 2008;128:1286-93. 8. Smith TM, Cong Z, Gilliland KL, et al. Insulin-like Growth Factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1. J Invest Dermatol 2006;126:1226-32. 9. Deplewski D, Rosenfiled RL. Role of hormones in pilosebaceous unit development. Endocr Rev 2000;21:363-92.
10. Vora S, Ovhal A, Jerajani H, et al. Correlation of facial sebum to serum Insulin-like Growth Factor-1 in patients with acne. Br J Dermatol 2008;159:979-95. 11. Aizawa H, Niimura M. Elevated serum insulin like-growth factor-1 (IGF-1) levels in women with postadolescent acne. J Dermatol 1995;22(4):249-52. 12. Cappel M, Muager D, Thiboutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol 2005;141:333-38. 13. Kaymak Y, Adisen E, Ilter N, dkk. Dietary glycemix index and glucose, insulin, insulinlike growth factor-1, insulin-like growth factor binding protein 3, and leptin levels in patiens with acne. J Am Acad Dermatol 2007;57:819-23. 14. Cordain L, Lindenberg S, et al. Acne vulgaris. Arch Dermatol.2002;138:1584-90. 15. Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne : a review of clinical features. Br J Dermatol. 1997;136:66-70 16. Olutunmbi Y, Paley K, English JC. Adolescent female acne : etiology and management. J Pediatr Adolesc Gynecol 2008;21:171-6. 17. Tan HH, Tan AWH, Barkham T, Yan XY, Zhu M. Community-based study of acne vulgaris in adolescents in Singapore. Br J Dermatol 2007;157:547-51 18. Tan JK, Vasey K, Fung KY. Beliefs and perceptions of patients with acne. J Am Acad Dermatol.2001;44:439-45. 19. Cunliffe WJ. Sebaceous gland physiology. Dalam : Cunliffe WJ, Acne. Edisi pertama. Martin Dunitz LTD, London 2001.h.123-39. 20. Cunliffe WJ. Biochemistry of the pilosebaceous unit. Dalam : Cunliffe WJ, Acne. Edisi pertama. Martin Dunitz LTD, London 2001.h.163-77. 21. Gollnick H. Current concepts of the pathogenesis of acne. Drugs 2003;63:1579-96.
22. Pham-Huu-Trung MT, Villetee JM, Dunclos JM, et al. Effects of Insulin-like Growth Factor-1 (IGF-1) on enzymatic activity in human adrenocortical cells interactions with ACTH. J. Steroid Biochem. Molec. Biol.1991;39:903-9. 23. Pochi PE. Acne : androgens and microbiology. Drug Development Research 1988;13:157-68. 24. Cunliffe WJ. Natural history of acne. Dalam : Cunliffe WJ, Acne. Edisi pertama. Martin Dunitz LTD, London 2001.h.2-10. 25. White GM. Recent findings in the epidemiologic evidence, classification and subtype of acne vulgaris. J Am Acad Dermatol 1998;39:S34-7. 26. Cunliffe WJ. Clinical assessment of acne. Dalam : Cunliffe WJ, Acne. Edisi pertama. Martin Dunitz LTD, London 2001.h.115-22. 27. Witkowski JA, Parish LC. The assessment of acne : an evaluation of grading and lesion counting in the measurement of acne. Clinics in Dermatology 2004; 23:394-97. 28. Nobukazu H, Akamatsu H, Kawashima M. Establishment of grading criteria for acne severity. J Dermatol 2008;35:255-60. 29. Lehmann HP, Robinson KA, Andrews JS, et al. Acne therapy : A methodologic review. J Am Acad Dermatol 2002;47:231-40. 30. Cunliffe WJ, Gollnick GHM. Clinical features. Acne : Diagnosis and management. London : Martin Dunitz;2001.h.49-81. 31. Froesch ER, Hussain MA, Schmid C. Insulin-like Growth Factor-1 : physiology, metabolic effects and clinical uses. Diabetes/Metabolism Reviews 1996;12: 192-215. 32. Wu XK, Sallinen K, Zhou SY, et al. Androgen excess contributes to altered growth hormone/insulin-like Growth Factor-1 axis in nonobese women with polycystic ovary syndrome. Fertility and Sterility 2000;73:730-4.
33. Etgen AM, Flores OG, Todd BJ. The role of Insulin-like Growth Factor-1 and growth factor-associated signal transduction pathways in estradiol and progesterone facilitation of female reproductive behaviors. Frontiers in Neuroendocrinology 2006;27:363-75. 34. Horton R, Pasupuletti V, Antonpillai I. Androgen induction of steroid 5α-reductase may be mediated via Insulin-like Growth Factor-1. Endocrinology 1993;133:447-51. 35. Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH. Perkiraan besar sampel. Dalam : Sastroasmoro S, Ismael S, editor. Dasar-dasar Metodologi Penelitian Klinis. Edisi ke-3. Jakarta : Sagung Seto, 2008.h.302-30. 36. Capitanio B, Sinagra JL, Ottaviani M, Bordignon V, Amantea A, Picardo M. Smoker s acne : a new clinical entity? Br J Dermatol. 2007;157:1070-1. 37. Hall K, Enberg G, Ritzen M, dkk. Somatomedin: A levels in serum from healthy children and from children with growth hormone deficiency or delayed puberty. Acta Endocrinol (Copenh) 1980;94:155-65. 38. Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. BMJ 1997;1:1109-10. 39. Dao H, Kazin RA. Gender differences in skin : a review of the literature. Gender Medicine 2007;4:308-28. 40. Kaklamani VG, Lions A, Kaklamani E, Lions A, dkk. Age, sex, and smoking are predictors of circulating insulin-like growth factor-1 and insulin-like growth factorbinding protein 3. J Clin Oncol 1999;17:813-7. 41. Parekh N, Roberts C, Vadiveloo M, dkk. Lifestyle, anthropometric, and obesity-related physiologic determinants if insulin-like gowth factor-1 in the Third National Health and Nutrition Examination Survey (1988-1994). Ann Epidemiol 2010;20: 182-93.
42. Badger JM, Berrigan D, Barbash B, Potischman N. Anthropometric correlated of insulinlike growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethinicity and gender. Ann Epidemiol 2009;841-9. 43. Janssen JAM, Stolk RP, Pols HA, Lamberts SWJ. Serum free IGF-1, total IGF-1, IGFBP- 1 and IGFBP-3 levels in an elderly population : relation to age and sex steroid levels. Clinical Endocrinology 1998;48:471-8.